Sanofi Consumer Healthcare is working with digital health firm ResApp to develop a mobile application which consumers can use to diagnose and manage respiratory illnesses. Such a tool has the potential to support novel Rx-to-OTC switch applications in future.
Sanofi Consumer Healthcare has entered into collaboration with Australia’s ResApp Health to develop a smartphone application for the diagnosis and management of respiratory disease.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.
Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.
Petros will incorporate into its platform an analytics firm’s automated document capture and authentication system leveraging its global ID library to verify identity and eligibility of consumers accessing the self-selection process for an ACNU switch.
